We recently compiled a list of the 15 Best S&P 500 Dividend Stocks to Buy Now. In this article, we are going to take a look ...

The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with ...

Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to ...

Medtronic beat Wall Street estimates for third-quarter profit on Tuesday, partly helped by demand for its diabetes devices, ...

The global Biopsy Devices Market, valued at US$6.86 billion in 2023, is forecasted to grow at a robust CAGR of 7.2%, reaching ...

Medtronic announced that investigators enrolled the first patient in a pivotal trial of its Prevail drug-coated balloon (DCB) ...

The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...

Medtronic has received approval from the FDA for BrainSense, its aDBS therapy for patients living with Parkinson’s disease.

For the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...

The revenue miss came as sales at Medtronic's Medical Surgical division declined 1.9% to $2.07 billion. The company pointed ...

As a prominent player in the medical technology sector, Medtronic benefits from a strong market position. However, the company faces intense competition and must continually innovate to maintain its ...

Brainomix announced today that it entered into a strategic partnership with the Medtronic Neurovascular business unit.